Cargando…
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling
Hyperinflammation plays an important role in severe and critical COVID-19. Using inconsistent criteria, many researchers define hyperinflammation as a form of very severe inflammation with cytokine storm. Therefore, COVID-19 patients are treated with anti-inflammatory drugs. These drugs appear to be...
Autores principales: | Hasan, Djo, Shono, Atsuko, van Kalken, Coenraad K., van der Spek, Peter J., Krenning, Eric P., Kotani, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578920/ https://www.ncbi.nlm.nih.gov/pubmed/34757513 http://dx.doi.org/10.1007/s11302-021-09814-6 |
Ejemplares similares
-
Purinergic signaling in testes revealed
por: Björkgren, Ida, et al.
Publicado: (2016) -
Excessive Extracellular ATP Desensitizes P2Y2 and P2X4 ATP Receptors Provoking Surfactant Impairment Ending in Ventilation-Induced Lung Injury
por: Hasan, Djo, et al.
Publicado: (2018) -
Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury
por: Hasan, Djo, et al.
Publicado: (2017) -
COVID‐19: lambda interferon against viral load and hyperinflammation
por: Andreakos, Evangelos, et al.
Publicado: (2020) -
Clinical implication of monitoring regional ventilation using electrical impedance tomography
por: Shono, Atsuko, et al.
Publicado: (2019)